132 related articles for article (PubMed ID: 35930716)
1. 18F-Fluciclovine PET/CT: A Potential Imaging Biomarker for the Evaluation of Multiple Myeloma.
Marcus C; Schuster DM; Tajmir SH
Clin Nucl Med; 2022 Sep; 47(9):e613-e615. PubMed ID: 35930716
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer.
Chen B; Wei P; Macapinlac HA; Lu Y
Nucl Med Commun; 2019 Sep; 40(9):940-946. PubMed ID: 31343613
[TBL] [Abstract][Full Text] [Related]
4. Detection of Additional Primary Neoplasms on
Parihar AS; Schmidt LR; Dehdashti F; Wahl RL
J Nucl Med; 2022 May; 63(5):713-719. PubMed ID: 34413144
[TBL] [Abstract][Full Text] [Related]
5. Incidental Spinal Meningioma on an 18F-Fluciclovine PET/CT.
Marcus C; Baugnon K; Schuster DM
Clin Nucl Med; 2022 Mar; 47(3):e313-e314. PubMed ID: 35025777
[TBL] [Abstract][Full Text] [Related]
6. Prostate Cancer Liver Metastases Presenting as Relatively Photopenic Lesions on 18F-Fluciclovine PET/CT.
Baiomy A; Martiniova L; Efstathiou E; Schuster DM; Ravizzini G
Clin Nucl Med; 2021 Apr; 46(4):e240-e241. PubMed ID: 33208612
[TBL] [Abstract][Full Text] [Related]
7. Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
Odewole OA; Tade FI; Nieh PT; Savir-Baruch B; Jani AB; Master VA; Rossi PJ; Halkar RK; Osunkoya AO; Akin-Akintayo O; Zhang C; Chen Z; Goodman MM; Schuster DM
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1773-83. PubMed ID: 27091135
[TBL] [Abstract][Full Text] [Related]
8. Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer.
Farkas AB; Green ED; Thaggard AL; Vijayakumar V; Henegan JC; Lirette ST; Nittala MR; Vijayakumar S
South Med J; 2021 Nov; 114(11):703-707. PubMed ID: 34729614
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Utility of
Nakamoto R; Harrison C; Song H; Guja KE; Hatami N; Nguyen J; Moradi F; Franc BL; Aparici CM; Davidzon G; Iagaru A
Mol Imaging Biol; 2021 Aug; 23(4):614-623. PubMed ID: 33469884
[TBL] [Abstract][Full Text] [Related]
10. Superscan 18F-Fluciclovine PET/CT of PSA-Negative Prostate Cancer Bone Metastases.
Chen B; Macapinlac HA; Lu Y
Clin Nucl Med; 2019 Apr; 44(4):337-338. PubMed ID: 30688749
[TBL] [Abstract][Full Text] [Related]
11. Multifocal Meningiomas Mimicking Dural-Based Intracranial Metastases at 18F-Fluciclovine PET/CT.
Manganaro MS; Millet JD; Manganaro MS
Clin Nucl Med; 2019 Jul; 44(7):594-595. PubMed ID: 31107759
[TBL] [Abstract][Full Text] [Related]
12. Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer.
Baiomy A; Jensen CT; Ward JF; Chasen BA; Ravizzini GC
Clin Nucl Med; 2021 Apr; 46(4):355-357. PubMed ID: 33323736
[TBL] [Abstract][Full Text] [Related]
13. Incidental Serous Cystadenoma Presenting as a Photopenic Pancreatic Defect on 18F-Fluciclovine PET/CT.
Waltz J; Mercer MK; Dani G; Rieter WJ
Clin Nucl Med; 2021 Dec; 46(12):e600-e602. PubMed ID: 34735415
[TBL] [Abstract][Full Text] [Related]
14. Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer.
Baiomy A; Schellingerhout D; Chapin BF; Weinberg JS; Raza SM; Macapinlac H; Ravizzini G
Nucl Med Commun; 2021 Jul; 42(7):755-762. PubMed ID: 33741867
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial.
Suzuki H; Jinnouchi S; Kaji Y; Kishida T; Kinoshita H; Yamaguchi S; Tobe T; Okamura T; Kawakita M; Furukawa J; Otaka A; Kakehi Y
Jpn J Clin Oncol; 2019 Sep; 49(9):803-811. PubMed ID: 31095314
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal Stromal Tumor Incidentally Detected on 18F-Fluciclovine PET/CT.
Raghavan K; Flavell RR; Westphalen AC; Behr SC
Clin Nucl Med; 2021 Apr; 46(4):345-347. PubMed ID: 33234933
[TBL] [Abstract][Full Text] [Related]
17. Complementary Role of 18 F-Fluciclovine PET/CT and 18 F-NaF PET/CT in Detecting Prostate Cancer Metastasis.
Xu F; Liu F; Chen W
Clin Nucl Med; 2023 Apr; 48(4):330-331. PubMed ID: 36716502
[TBL] [Abstract][Full Text] [Related]
18. Detection of Adenocarcinoma of the Colon on 18 F-Fluciclovine PET/CT.
Desai C; Clark A; Surasi DS; Flynt L
Clin Nucl Med; 2024 Jun; 49(6):543-545. PubMed ID: 38598733
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18-Labeled Fluciclovine PET/CT in Primary and Biochemical Recurrent Prostate Cancer Management.
Marcus C; Butler P; Bagrodia A; Cole S; Subramaniam RM
AJR Am J Roentgenol; 2020 Aug; 215(2):267-276. PubMed ID: 32551903
[No Abstract] [Full Text] [Related]
20. Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer.
Teoh EJ; Tsakok MT; Bradley KM; Hyde K; Subesinghe M; Gleeson FV
Clin Nucl Med; 2017 Oct; 42(10):803-804. PubMed ID: 28806256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
